V.V. Filiche6 et al. / Carbohydrate Research 333 (2001) 115–122
121
psi. The solution was filtered through Celite®
and washed thoroughly with water and evapo-
rated in vacuo giving the title compound 26
(93 mg, 90%) as a brown foam, which could
be purified by silica-gel column chromatogra-
phy (0–30% (v/v) aq NH3 in dioxane): Rf 0.10
3), 66.4 (Fmoc), 69.4, 70.1, 70.6, 70.7
(CH[OH]CH2OH), 118.8, 123.9, 126.0, 126.6,
140.4, 143.0, 154.5 (Fmoc); FAB-MS m/z 370
[M+H+].
N-Fmoc-(3R,4R)-4-(hydroxymethyl)pyrro-
lidin-3-ol (19).—A cooled solution of com-
pound 18 (724 mg, 1.96 mmol) in EtOH (10
mL) was added to a solution of NaIO4 (461
mg, 2.16 mmol) in water (5 mL) while stirring.
After 30 min, NaBH4 (217 mg, 5.86 mmol)
was added. After 30 min the resulting solution
was diluted with water (10 mL) and extracted
with CH2Cl2 (3×50 mL). The combined or-
ganic layers were dried (Na2SO4) and evapo-
rated under diminished pressure to give pure
19 (660 mg, 99%): Rf 0.52 (10% MeOH–
1
(50% aq NH3–1,4-dioxane); H NMR (D2O):
l 2.57 (sep, 1 H, J 3.7 Hz, H-4), 3.10 (dd, 1 H,
J 7.0, 12.0 Hz, H-5), 3.16 (dd, 1 H, J 2.7, 12.5
Hz, H-2), 3.32 (dd, 1 H, J 5.4, 12.4 Hz, H-5),
3.50–3.70 (m, 5 H, H-2, ꢀCH[OH]CH[OH]-
CH2OH), 4.57 (td, 1 H, J 3.1, 5.3 Hz, H-3),
13
4.78 (m, 5 H, NH, 4×OH); C NMR (D2O):
l 47.9 (C-4), 48.5 (C-5), 53.6 (C-2), 63.3
(CH2OH), 71.3, 71.4 (ꢀCH[OH]CH[OH]ꢀ),
73.5 (C-3); HRMS (FAB) m/z 178.1078
([MH]+ [C7H16NO4]=178.1079).
1
CH2Cl2); H NMR (CDCl3): l 2.30 (br.s, 1 H,
H-4), 3.20 (m, 1 H, H-5), 3.32 (m, 1 H, H-5),
3.40–3.70 (m, 5 H, H-2, CH2OH, CH
[Fmoc]), 4.20–4.38 (m, 5 H, CH2 [Fmoc], H-3,
2×OH), 7.25–7.83 (m, 8 H, [Fmoc]). 13C
NMR (CDCl3): l 46.4, 46.6 (C-4), 47.2, 47.5
(C-5), 48.2 (Fmoc), 52.4, 52.8 (C-2), 62.4 (C-
3), 67.4 (Fmoc), 71.8, 72.6 (CH2OH), 119.9,
125.0, 126.0, 127.7, 141.2, 143.8, 155.2
(Fmoc); FAB-MS m/z 340 [M+H]+.
References
1. Bols, M. Acc. Chem. Res. 1998, 31, 1–8.
2. Ichikawa, Y.; Igarashi, Y.; Ichicawa, M.; Suhara, Y. J.
Am. Chem. Soc. 1998, 120, 3007–3018.
3. Ichikawa, Y.; Igarashi, Y.; Ichicawa, M. Tetrahedron
Lett. 1995, 36, 1767–1770.
4. Jaeger, E.; Biel, J. H. J. Org. Chem. 1965, 30, 740–744.
5. Lee, Y. H.; Kim, H. K.; Youn, I. K.; Chae, Y. B. Bioorg.
Med. Chem. Lett. 1991, 1, 287–290.
6. Sørensen, M. D.; Khalifa, N. M.; Pedersen, E. B. Synthe-
sis 1999, 1937–1943.
(3R,4R)-4-(Hydroxymethyl)pyrrolidin-3-ol
(3).—A mixture of compound 19 (520 mg,
1.53 mmol) and Et3N (0.65 mL, 4.70 mmol) in
MeCN (30 mL) was stirred at 60 °C for 15 h.
The solvent was removed in vacuo and the
residue was dissolved in CH2Cl2 (10 mL)–wa-
ter (30 mL) and washed with CH2Cl2 (2×30
mL). The water layer was concentrated under
diminished pressure to yield 3 (171 mg, 95%):
7. Bols, M.; Persson, M. P.; Butt, W. M.; Jørgensen, M.;
Christensen, P.; Hansen, L. T. Tetrahedron Lett. 1996, 37,
2097–2100.
8. Godskesen, M.; Lundt, I. Tetrahedron Lett. 1998, 39,
5841–5844.
9. Bols, M.; Hansen, S. U. Acta Chem. Scand. 1998, 52,
1214–1222.
10. Ichikawa, Y.; Makino, K. Tetrahedron Lett. 1998, 39,
1
Rf 0.41 (50% aq NH3 –1,4-dioxane); H NMR
8245–8248.
11. Kowollik, W.; Janairo, G.; Voelter, W. J. Org. Chem.
1988, 53, 3943–3947.
12. Bashyal, B. P.; Fleet, G. W. J.; Gough, M. J.; Smith, P.
W. Tetrahedron 1987, 43, 3083–3093.
13. Farr, R. A.; Holland, A. K.; Huber, E. W.; Peet, N. P.;
Weintraub, P. M. Tetrahedron 1994, 50, 1033–1044.
14. Moravcova, J.; Capkova, J.; Stanek, J. Carbohydr. Res.
1994, 263, 61–66.
15. Yoshimura, Y.; Sano, T.; Matsuda, A.; Ueda, T. Chem.
Pharm. Bull. 1988, 36, 162–167.
16. Calvo-Mateo, A.; Camarasa, M.-J.; Diaz-Ortiz, A.; de las
Heras, F. G. J. Chem. Soc., Chem. Commun. 1988, 1114–
1115.
17. Calvo-Mateo, A.; Camarasa, M.-J.; Diaz-Ortiz, A.; de las
Heras, F. G. Tetrahedron 1988, 44, 4895–4903.
18. Lin, T.-S.; Zhu, J.-L.; Dutschman, G. E.; Cheng, Y.-C.;
Prusoff, W. H. J. Med. Chem. 1993, 36, 353–362.
19. Acton, E. M.; Goerner, R. N.; Uh, H. S.; Ryan, K. J.;
Henry, D. W. J. Med. Chem. 1979, 22, 518–525.
(CD3OD): l 2.20 (m, 1 H, H-4), 2.74 (dd, 1 H,
J 5.7, 11.4 Hz, H-5), 2.85 (dd, 1 H, J 3.1, 12.1
Hz, H-2), 3.10 (dd, 1 H, J 5.2, 12.0 Hz, H-5),
3.20–3.28 (m, 1 H, H-2), 3.45–3.60 (m, 2 H,
CH2OH), 4.15 (td, 1 H, J 3.3, 5.1 Hz, H-3),
13
4.79 (m, 3 H, 2×OH, NH); C NMR (D2O):
l 73.5 (C-3), 61.9 (CH2OH), 54.3 (C-2), 50.7
(C-5), 48.1 (C-4); HRMS (FAB) m/z 118.0868
([MH]+ [C5H12NO2]=118.0864).
(3R,4S) - 4 - [(1S,2R) - 1,2,3 - Trihydroxypro-
pyl]pyrrolidin-3-ol
(26).—3-Deoxy-3-C-ni-
-allose (25, 130 mg, 0.58 mmol)
tromethyl-
D
was dissolved in 10 mL of water, and 10%
Pd–C (46 mg) was added. The solution was
hydrogenated in an autoclave for 24 h at 200